| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $28.64B | 20.50 | 16.86% | ― | 31.16% | 11.97% | |
62 Neutral | $3.86B | 20.42 | 20.31% | ― | 20.97% | 226.98% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $4.79B | ― | -61.90% | ― | 3.27% | -81.63% | |
54 Neutral | $1.28B | ― | ― | 10.79% | -30.26% | -156.69% | |
40 Underperform | $1.95B | ― | -131.02% | ― | -36.07% | -233.14% | |
40 Underperform | $25.14K | >-0.01 | ― | ― | 16.55% | 15.72% |